DNA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ginkgo Bioworks Holdings Inc

Watchlist Manager

Watchlist

Price: 9.37 USD 4.81% Market Closed

Market Cap: $583.9m

	Ginkgo Bioworks Holdings Inc NYSE:DNA	US
	Fast Retailing Co Ltd TSE:9983	JP
	Agricultural Bank of China Ltd SSE:601288	CN
C	California Software Company Ltd BSE:532386	IN
	Jungfraubahn Holding AG F:J4F	CH
M	Mirasol Resources Ltd F:M8R	CA
	Kering SA PAR:KER	FR
T	TUI AG LSE:TUI	DE
	Amada Co Ltd TSE:6113	JP
	Bukit Asam Tbk PT IDX:PTBA	ID
B	Bed Bath & Beyond Inc XBER:BBY	US

Profitability Summary

Ginkgo Bioworks Holdings Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

71% > 73%

Negative Operating Margin

-210%

Negative 3Y Average Operating Margin

-208%

Operating Margin is Increasing

-370% > -210%

Negative Net Margin

-215%

Negative 3Y Average Net Margin

-271%

Net Margin is Increasing

-376% > -215%

Negative Free Cash Flow Margin

-119%

Negative 3Y Average Free Cash Flow Margin

-140%

Declining Free Cash Flow Margin

-113% > -119%

Negative ROE

-56%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-54%

ROIC is Increasing

-135% > -42%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.